Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1978 Nov;14(5):755–760. doi: 10.1128/aac.14.5.755

Effect of Antibiotics on the Prevention of Experimental Bacteroides fragilis Endocarditis

Peggy L Goldman 1, David T Durack 2, Robert G Petersdorf 1
PMCID: PMC352546  PMID: 727764

Abstract

The relative efficacy of single doses of antibiotics in modifying the development of Bacteroides fragilis subsp. fragilis endocarditis was studied in an experimental model. Antibiotics were administered 0.5 h before intravenous injection of B. fragilis subsp. fragilis into rabbits prepared by insertion of a polyethylene catheter into the left side of the heart; 48 h later, intracardiac vegetations were excised and cultured anaerobically. B. fragilis was recovered from 92% of untreated animals. After a single dose of procaine penicillin G (250 mg/kg intramuscularly), 80% of the animals remained infected. Chloramphenicol (30 mg/kg), carbenicillin (50 mg/kg), and metronidazole (10 mg/kg) were also ineffective (76, 80, and 75% infected, respectively). Cefamandole (30 mg/kg), cefoxitin (30 mg/kg), and erythromycin (30 mg/kg) were significantly more active (50, 55, and 45% infected, respectively), as were higher doses of carbenicillin. Clindamycin (50 mg/kg) was the most effective regimen (11% infected). At present, the relevance of these results to the therapy of serious B. fragilis infections is not known, but this model may prove useful in the evaluation of the prevention of B. fragilis subsp. fragilis bacteremia.

Full text

PDF
755

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bartlett J. G., Finegold S. M. Anaerobic infections of the lung and pleural space. Am Rev Respir Dis. 1974 Jul;110(1):56–77. doi: 10.1164/arrd.1974.110.1.56. [DOI] [PubMed] [Google Scholar]
  2. Bennett J. V., Brodie J. L., Benner E. J., Kirby W. M. Simplified, accurate method for antibiotic assay of clinical specimens. Appl Microbiol. 1966 Mar;14(2):170–177. doi: 10.1128/am.14.2.170-177.1966. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Busch D. F., Sutter V. L., Finegold S. M. Activity of combinations of antimicrobial agents against Bacteroides fragilis. J Infect Dis. 1976 Mar;133(3):321–328. doi: 10.1093/infdis/133.3.321. [DOI] [PubMed] [Google Scholar]
  4. Carrizosa J., Tanphaichitra D., Levison M. E. Experimental Bacteroides fragilis endocarditis in rabbits. Infect Immun. 1977 Mar;15(3):871–873. doi: 10.1128/iai.15.3.871-873.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Chow A. W., Guze L. B. Bacteroidaceae bacteremia: clinical experience with 112 patients. Medicine (Baltimore) 1974 Mar;53(2):93–126. [PubMed] [Google Scholar]
  6. Douglas R. L., Kislak J. W. Treatment of Bacteroides fragilis bacteremia with clindamycin. J Infect Dis. 1973 Oct;128(4):569–571. doi: 10.1093/infdis/128.4.569. [DOI] [PubMed] [Google Scholar]
  7. Durack D. T., Beeson P. B., Petersdorf R. G. Experimental bacterial endocarditis. 3. Production and progress of the disease in rabbits. Br J Exp Pathol. 1973 Apr;54(2):142–151. [PMC free article] [PubMed] [Google Scholar]
  8. Durack D. T., Beeson P. B. Protective role of complement in experimental Escherichia coli endocarditis. Infect Immun. 1977 Apr;16(1):213–217. doi: 10.1128/iai.16.1.213-217.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Durack D. T., Starkebaum M. K., Petersdorf R. G. Chemotherapy of experimental streptococcal endocarditis. VI. Prevention of enterococcal endocarditis. J Lab Clin Med. 1977 Jul;90(1):171–179. [PubMed] [Google Scholar]
  10. Ernst E. C., Berger S., Barza M., Jacobus N. V., Tally F. P. Activity of cefamandole and other cephalosporins against aerobic and anaerobic bacteria. Antimicrob Agents Chemother. 1976 May;9(5):852–855. doi: 10.1128/aac.9.5.852. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. FINLAND M. Treatment of bacterial endocarditis. N Engl J Med. 1954 Mar 4;250(9):372–contd. doi: 10.1056/NEJM195403042500906. [DOI] [PubMed] [Google Scholar]
  12. Felner J. M., Dowell V. R., Jr Anaerobic bacterial endocarditis. N Engl J Med. 1970 Nov 26;283(22):1188–1192. doi: 10.1056/NEJM197011262832203. [DOI] [PubMed] [Google Scholar]
  13. Gorbach S. L., Bartlett J. G. Anaerobic infections. 1. N Engl J Med. 1974 May 23;290(21):1177–1184. doi: 10.1056/NEJM197405232902106. [DOI] [PubMed] [Google Scholar]
  14. Griffith R. S., Brier G. L., Wolny J. D. Synergistic action of erythromycin and cefamandole against Bacteroides fragilis subsp. fragilis. Antimicrob Agents Chemother. 1977 May;11(5):813–816. doi: 10.1128/aac.11.5.813. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Hackman A. S., Wilkins T. D. Comparison of cefoxitin and cephalothin therapy of a mixed Bacteroides fragilis and Fusobacterius necrophorum infection in mice. Antimicrob Agents Chemother. 1975 Aug;8(2):224–225. doi: 10.1128/aac.8.2.224. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Hewitt W. L., Seligman S. J., Deigh R. A. Kinetics of the synergism of penicillin-streptomycin and penicillin-kanamycin for enterococci and its relationship to L-phase variants. J Lab Clin Med. 1966 May;67(5):792–807. [PubMed] [Google Scholar]
  17. Jones R. N., Fuchs P. C. Identification and antimicrobial susceptibility of 250 Bacteriodes fragilis subspecies tested by broth microdilution methods. Antimicrob Agents Chemother. 1976 Apr;9(4):719–721. doi: 10.1128/aac.9.4.719. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Leigh D. A. Clinical importance of infections due to Bacteroides fragilis and role of antibiotic therapy. Br Med J. 1974 Jul 27;3(5925):225–228. doi: 10.1136/bmj.3.5925.225. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Levison M. E., Santoro J., Bran J. L., Ries K., Rubin W. In vitro activity and clinical efficacy of clindamycin in the treatment of infections due to anaerobic bacteria. J Infect Dis. 1977 Mar;135 (Suppl):S49–S53. doi: 10.1093/infdis/135.supplement.s49. [DOI] [PubMed] [Google Scholar]
  20. Marcoux J. A., Zabransky R. J., Washington J. A., 2nd, Wellman W. E., Martin W. J. Bacteroides bacteremia. Minn Med. 1970 Nov;53(11):1169–1176. [PubMed] [Google Scholar]
  21. Martin W. J., Gardner M., Washington J. A., 2nd In vitro antimicrobial susceptibility of anaerobic bacteria isolated from clinical specimens. Antimicrob Agents Chemother. 1972 Feb;1(2):148–158. doi: 10.1128/aac.1.2.148. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Meny R., Webb C. D., Fiedelman W. Carbenicillin therapy of anaerobic infections. Curr Ther Res Clin Exp. 1975 May;17(5):478–487. [PubMed] [Google Scholar]
  23. Nastro L. J., Finegold S. M. Endocarditis due to anaerobic gram-negative bacilli. Am J Med. 1973 Apr;54(4):482–496. doi: 10.1016/0002-9343(73)90044-2. [DOI] [PubMed] [Google Scholar]
  24. Onderdonk A. B., Bartlett J. G., Louie T., Sullivan-Seigler N., Gorbach S. L. Microbial synergy in experimental intra-abdominal abscess. Infect Immun. 1976 Jan;13(1):22–26. doi: 10.1128/iai.13.1.22-26.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Pelletier L. L., Jr, Durack D. T., Petersdorf R. G. Chemotherapy of experimental streptococcal endocarditis. IV. Further observations on prophylaxis. J Clin Invest. 1975 Aug;56(2):319–330. doi: 10.1172/JCI108096. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. RANTZ L. A. Bacteroides endocarditis; report of a case successfully treated with terramycin. J Am Med Assoc. 1951 Sep 8;147(2):124–124. doi: 10.1001/jama.1951.73670190003006a. [DOI] [PubMed] [Google Scholar]
  27. Ralph E. D., Clarke J. T., Libke R. D., Luthy R. P., Kirby W. M. Pharmacokinetics of metronidazole as determined by bioassay. Antimicrob Agents Chemother. 1974 Dec;6(6):691–696. doi: 10.1128/aac.6.6.691. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Ralph E. D., Kirby W. M. Unique bactericidal action of metronidazole against Bacteroides fragilis and Clostridium perfringens. Antimicrob Agents Chemother. 1975 Oct;8(4):409–414. doi: 10.1128/aac.8.4.409. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Sande M. A., Johnson M. L. Antimicrobial therapy of experimental endocarditis caused by Staphylococcus aureus. J Infect Dis. 1975 Apr;131(4):367–375. doi: 10.1093/infdis/131.4.367. [DOI] [PubMed] [Google Scholar]
  30. Standiford H. C., Jordan M. C., Kirby W. M. Clinical pharmacology of carbenicillin compared with other penicillins. J Infect Dis. 1970 Sep;122(Suppl):S9–13. doi: 10.1093/infdis/122.supplement_1.s9. [DOI] [PubMed] [Google Scholar]
  31. Tally F. P., Sutter V. L., Finegold S. M. Treatment of anaerobic infections with metronidazole. Antimicrob Agents Chemother. 1975 May;7(5):672–675. doi: 10.1128/aac.7.5.672. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Thörig L., Thompson J., Eulderink F. Effect of warfarin on the induction and course of experimental Staphylococcus epidermidis endocarditis. Infect Immun. 1977 Sep;17(3):504–509. doi: 10.1128/iai.17.3.504-509.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Walker C. B., Nitzan D., Wilkins T. D. Chemotherapy of an experimental Bacteroides fragilis infection in mice. Antimicrob Agents Chemother. 1977 Mar;11(3):435–440. doi: 10.1128/aac.11.3.435. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Walker C. B., Wilkins T. D. Use of semisolid agar from initiation of pure Bacteroides fragilis infection in mice. Infect Immun. 1976 Sep;14(3):721–725. doi: 10.1128/iai.14.3.721-725.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Young L. S., Martin W. J., Meyer R. D., Weinstein R. J., Anderson E. T. Gram-negative rod bacteremia: microbiologic, immunologic, and therapeutic considerations. Ann Intern Med. 1977 Apr;86(4):456–471. doi: 10.7326/0003-4819-86-4-456. [DOI] [PubMed] [Google Scholar]
  36. Zabransky R. J., Johnston J. A., Hauser K. J. Bacteriostatic and bactericidal activities of various antibiotics against Bacteroides fragilis. Antimicrob Agents Chemother. 1973 Feb;3(2):152–156. doi: 10.1128/aac.3.2.152. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES